Msafe Equipments IPO received bids for around 284.92 million shares against an offer size of 3.87 million shares ...
Going forward, I Peace will accelerate the development of next-generation immune cell and regenerative medicine platforms by expanding its lineup of immune cell–derived iPS cells and by supplying ...
Rising regulatory compliance requirements, rapid digital transformation in pharmaceutical manufacturing, and increasing focus on patient safety are driving the pharmaceutical quality management ...
The 2026 revision of the Implementing Regulation of the Drug Administration Law, effective May 15, 2026, was recently passed by China’s State Council.
Scientific Innovation and Advanced R&D Capabilities China is a leader in the beauty industry thanks to its growing research ecosystem. Leading manufacturers have moved away from outsourcing production ...
An informational overview examining category context, publicly available product disclosures, and what consumers often ...
Managing chronic conditions requires consistent medication. Yet ordering from an online pharmacy at the last minute often ...
An informational overview examining category context, publicly available product disclosures, and what consumers often ...
Topfeel’s Design-Driven Culture of Innovation Topfeel’s unique engineering-led system is at the core of its capabilities.
Earlier this week, integrated development and manufacturing organization (IDMO) Cellares announced the closing of its latest ...
The IPO of Msafe Equipments opened on January 28 and was oversubscribed 73.23 times by 1:30 PM. The company aims to raise ₹54.2 crore at a price of ₹123 per share, with strong interest from retail, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results